Skip to main content
SSO 2024 Annual Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded for On-Demand Viewing
Recorded for On-Demand Viewing
Back

Melanoma

CME

Unanswered Questions in Melanoma in 2023

Friday, March 22, 2024
4:00pm – 5:00pm ET
Location:Georgia Ballroom

Recorded for On-Demand Viewing

    Moderator(s)

  • Christina Angeles, MD (she/her/hers)

    Surgical Oncologist
    Department of Surgery, Rogel Cancer Center, University of Michigan
    Ann Arbor, Michigan, United States

    Disclosure(s): SkylineDx: Research Grant (Ongoing)

  • Genevieve Boland, MD, PhD

    Section Head, Melanoma/Sarcoma Surgery
    Massachusetts General Hospital
    Boston, Massachusetts, United States

    Disclosure(s): Ankyra Therapeutics: Advisor (Ongoing), Consultant (Ongoing), Stocks (Ongoing); InterVenn Bioscience: Consultant (Terminated, January 2, 2023), Research Grant (Terminated, January 2, 2023); Iovance Biotherapeutics: Advisor (Terminated, June 1, 2023), Consultant (Terminated, June 1, 2023); Merck: Advisor (Terminated, June 1, 2023), Consultant (Terminated, June 1, 2023); Nektar Therapeutics: Advisor (Terminated, January 1, 2022); Olink Proteomics: Research Grant (Ongoing); Palleon Pharmaceuticals: Research Grant (Terminated, January 2, 2023); Teiko Bio: Research Grant (Ongoing)

Disclosure(s):
Christina V. Angeles, MD: SkylineDx: Research Grant (Ongoing)
Genevieve M. Boland, MD, PhD: Ankyra Therapeutics: Advisor (Ongoing), Consultant (Ongoing), Stocks (Ongoing); InterVenn Bioscience: Consultant (Terminated, January 2, 2023), Research Grant (Terminated, January 2, 2023); Iovance Biotherapeutics: Advisor (Terminated, June 1, 2023), Consultant (Terminated, June 1, 2023); Merck: Advisor (Terminated, June 1, 2023), Consultant (Terminated, June 1, 2023); Nektar Therapeutics: Advisor (Terminated, January 1, 2022); Olink Proteomics: Research Grant (Ongoing); Palleon Pharmaceuticals: Research Grant (Terminated, January 2, 2023); Teiko Bio: Research Grant (Ongoing)

This Melanoma CME session will cover some contemporary challenges facing those in clinical practice today, namely, how to improve access to care in patients who are in rural communities, understanding the options for treatment for recurrent melanoma and understanding the new landscape for the use of neoadjuvant immunotherapy for clinically advanced, but resectable melanoma.

Presentations:

  • 4:00pm – 4:15pm ET
    Melanoma in Rural and Frontier Communities: How to Mitigate Barriers and Optimize Outcomes

    Presenter: Elliot A. Asare, MD, MS, FACS (he/him/his) – University of Utah and Huntsman Cancer Institute

  • 4:15pm – 4:30pm ET
    Treatment Options for Recurrent Melanoma- How to Manage Local, Regional and Distant Recurrences?

    Presenter: Georgia M. Beasley, MD MHS (she/her/hers) – Duke University Medical Center

  • 4:30pm – 4:45pm ET
    Neoadjuvant Immunotherapy: What to Give, How Much, How Early and do you Need Additional Adjuvant Therapy?

    Presenter: Kelly Olino, MD (she/her/hers) – Yale School of Medicine, Department of Surgery

  • 4:45pm – 5:00pm ET
    Questions & Discussion